We read with interest the recently published article from Ricos et al. 1 The study systematically reviewed for the first time the important issue of the biological variation of laboratory tests drawn from patients and the differences toward the commonly available data obtained from healthy subjects. The authors collated a considerable amount of data and provided an important starting point for following investigations. We concord with the author's conclusions, in particular with regard to the statement that the biological variation of the most commonly used tumour markers shows significant differences if evaluated from healthy subjects or from patients.
In the framework of a study about tumour markers biological variation, we produced data also for CEA and CA 15.3. The study details were previously described. 2 Briefly, venous blood was obtained from 12 healthy female and 10 male subjects (only the 12 female subjects for CA15.3) once a month for four months (five specimens per subject), stored at 2808C and assayed on automatic platform ADVIA Centaur (Siemens Medical Solutions Diagnostics). In parallel, we selected 21 patients from a prospective study about the decision criteria of tumour markers in the follow-up of breast cancer, 3 in which six specimens for six months, (one specimen per month) were obtained, and that subsequently showed no evidence of disease for at least three years of follow-up.
Both the group of data were analysed with the nested ANOVA, and evaluated for possible outliers. 4 The results (Table 1) confirmed the data collected from Ricos et al. with within-subjects biological variation from healthy subjects in accord with the literature and the corresponding data from patients about 2.5 time higher. It is worth noting that the different variability should not be due to different monitoring period, since both the studies are comparable from this point of view.
Moreover, the distributions of the single subjects variability were clearly different between the healthy and patients groups, especially for CEA ( Figure 1 ). This finding is in accord with other studies, 5 -7 in which the individual critical difference was used to identify patients who developed recurrence and in which several cases showed the nontumour related variability too high to allow identification of minor clinically relevant tumour marker variations.
We can conclude that:
(1) the biological variation from healthy subjects should be considered a useful tool for the determination of quality specification; 8,9 (2) for some laboratory tests, as in the case of tumour markers, the biological variation obtained from healthy subjects could not be useful for critical difference evaluation; (3) the cumulative variability evaluated from patients could provide misleading results, and the individual critical difference for each patient, although difficult to obtain, could be the only way for the detection of clinically relevant variation.
Ruggero Dittadi 1 , Lucia Peloso 2 and Massimo Gion 1,2 Author's response
The letter from Dr Dittadi clearly illustrates the importance of considering information from each patient instead of data from a non-homogenous comparison group for the follow-up of patients. The reference change value, that is the difference between two consecutive results of the same analyte from the same person (also known as the critical difference) is a widely accepted method for detecting significant changes of patient status. Data from within-subject biological variations are the basis for defining the value that reflects a change and it is important to know that in some cases, this value should not be derived from the healthy population, due to different homeostatic regulation in quite a few non-healthy situations. We were aware of this fact and published a revision that put on the table evidences of this reality.
Thus, I think that efforts in this respect are very worthwhile and help clinical laboratory professionals towards improving the utility of their reports. This, consequently, enhances the quality of the health-care system. 
Carmen Ricos

Erratum
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